The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Oral supplementation with a combination of l-citrulline and l-arginine rapidly increases plasma l-arginine concentration and enhances NO bioavailability
Open accessAbstract
BACKGROUND: Chronic supplementation with L-citrulline plus L-arginine has been shown to exhibit anti-atherosclerotic effects. However, the short-term action of this combination on the nitric oxide (NO)-cGMP pathway remains to be elucidated. The objective of the present study was to investigate the acute effects of a combination of oral L-citrulline and L-arginine on plasma L-arginine and NO levels, as well as on blood circulation. METHODS: Rats or New Zealand white rabbits were treated orally with L-citrulline, or L-arginine, or a combination of each at half dosage. Following supplementation, plasma levels of L-arginine, NOx, cGMP and changes in blood circulation were determined sequentially. RESULTS: L-Citrulline plus L-arginine supplementation caused a more rapid increase in plasma L-arginine levels and marked enhancement of NO bioavailability, including plasma cGMP concentrations, than with dosage with the single amino acids. Blood flow in the central ear artery in rabbits was also significantly increased by L-citrulline plus L-arginine administration as compared with the control. CONCLUSION: Our data show for the first time that a combination of oral L-citrulline and L-arginine effectively and rapidly augments NO-dependent responses at the acute stage. This approach may have clinical utility for the regulation of cardiovascular function in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Citrulline, the end product of arginine-mediated nitric oxide production, has shown the potential to increase plasma nitrate and NO availability (Schwedhelm et al. 2007; Morita et al. 2014).”
From Oral nitrate and citrulline decrease blood pressure and increase vascular conductance in young adults: a potential therapy for heart failure (2016) · cites this paper as Morita et al. 2014
In the citing paper
“enhanced the bioavailability of nitric oxide (Morita et al. 2014)”
From Oral nitrate and citrulline decrease blood pressure and increase vascular conductance in young adults: a potential therapy for heart failure (2016) · cites this paper as Morita et al. 2014
Citations
Cites
Nitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,036
Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H. H. W., Nakane, M., & Murad, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10480 · Cited by 979
Nitric oxide, cell bioenergetics and neurodegeneration
Moncada, S., & Bolaños, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03988.x · Cited by 555
Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
Lerman, A., Burnett, J. C. J., Higano, S. T., McKinley, L. J., & Holmes, D. R. (1998) · Circulation · doi:10.1161/01.cir.97.21.2123 · Cited by 426
Diabetes-induced Coronary Vascular Dysfunction Involves Increased Arginase Activity
Romero, M. J., Platt, D. H., Tawfik, H. E., Labazi, M., El‐Remessy, A. B., Bartoli, M., Caldwell, R. B., & Caldwell, R. W. (2007) · Circulation Research · doi:10.1161/circresaha.107.155028 · Cited by 386
Regulation of Nitric Oxide Production by Arginine Metabolic Enzymes
Mori, M., & Gotoh, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3169 · Cited by 359
Schulman, S. P., Becker, L. C., Kass, D. A., Champion, H. C., Terrin, M. L., Forman, S., Ernst, K. V., Kelemen, M. D., Townsend, S. N., Capriotti, A., et al. (2006) · JAMA · doi:10.1001/jama.295.1.58 · Cited by 357
Dietary L-arginine supplementation reduces fat mass in Zucker diabetic fatty rats
Fu, W. J., Haynes, T. E., Kohli, R., Hu, J., Shi, W., Spencer, T. E., Carroll, R. J., Meininger, C. J., & Wu, G. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.4.714 · Cited by 353
Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351
Role of nitric oxide in cardiovascular disease: focus on the endothelium
Cannon, R. O. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1809 · Cited by 346
Ignarro, L. J., Buga, G. M., Liu, W., Bauer, P. M., Wu, G., & Soldato, P. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071054698 · Cited by 334
Coronary risk factors, endothelial function, and atherosclerosis: A review
Vogel, R. A. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200505 · Cited by 257
Regulation of Enzymes of Urea and Arginine Synthesis
Morris, S. M. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.000501 · Cited by 252
Therapeutic Use of Citrulline in Cardiovascular Disease
Romero, M. J., Platt, D. H., Caldwell, R. B., & Caldwell, R. W. (2006) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2006.00275.x · Cited by 231
Moinard, C., Nicolis, I., Neveux, N., Darquy, S., Bénazeth, S., & Cynober, L. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507841110 · Cited by 218
Oral L-arginine improves endothelial function in healthy individuals older than 70 years
Bode‐Böger, S. M., Muke, J., Surdacki, A., Brabant, G. E., Böger, R. H., & Frölich, J. C. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm474oa · Cited by 198
l -Arginine Prevents Xanthoma Development and Inhibits Atherosclerosis in LDL Receptor Knockout Mice
Aji, W., Stefano Ravalli, A., Szabolcs, M. J., Jiang, X.-C., Sciacca, R. R., Michler, R. E., & Cannon, P. (1997) · Circulation · doi:10.1161/01.cir.95.2.430 · Cited by 156
Hayashi, T., Juliet, P. A. R., Matsui‐Hirai, H., Miyazaki, A., Fukatsu, A., Funami, J., Iguchi, A., & Ignarro, L. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506595102 · Cited by 143
Self-citationShort-term effects of l-citrulline supplementation on arterial stiffness in middle-aged men
Ochiai, M., Hayashi, T., Morita, M., Ina, K., Maeda, M., Watanabe, F., & Morishita, K. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.004 · Cited by 127
Self-citationSimon, A., Plies, L., Habermeier, A., Martiné, U., Reining, M., & Closs, E. I. (2003) · Circulation Research · doi:10.1161/01.res.0000097761.19223.0d · Cited by 102
Hardy, T. A., & May, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00781-x · Cited by 101
Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen
Hayashi, T., Esaki, T., Muto, E., Kano, H., Asai, Y., Thakur, N. K., Sumi, D., Jayachandran, M., & Iguchi, A. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.782 · Cited by 98
Self-citationFigueroa, A., Sanchez-Gonzalez, M. A., Wong, A., & Arjmandi, B. H. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.20 · Cited by 96
Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis
Ignarro, L. J., & Claudio Napoli, A. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0059-9 · Cited by 91
El‐Bassossy, H. M., El‐Fawal, R., & Fahmy, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.01.001 · Cited by 83
Claudio Napoli, A., Ackah, E., de Nigris, F., Soldato, P. D., D’Armiento, F. P., Crimi, E., Condorelli, M., & Sessa, W. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192244499 · Cited by 74
Siasos, G., Tousoulis, D., Vlachopoulos, C. V., Antoniades, C. A., Stefanadi, E., Ioakeimidis, N., Andreou, I., Zisimos, K., Papavassiliou, A. G., & Stefanadis, C. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.057 · Cited by 68
Shin, S., Mohan, S., & Fung, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.112 · Cited by 65
Sušić, D., Francischetti, A., & Frohlich, E. D. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.451 · Cited by 55
El‐Kirsh, A. A. A., El-Wahab, H. M. F. A., & Sayed, H. F. A. (2011) · Cell Biochemistry and Function · doi:10.1002/cbf.1766 · Cited by 54
Elahi, M. M., Naseem, K. M., & Matata, B. M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05660.x · Cited by 53
Lin, C., Tsai, W., Chen, J., Li, Y., Lin, L.-J., & Chen, J.-H. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.013 · Cited by 53
Morita, M., Sakurada, M., Watanabe, F., Yamasaki, T., Doi, H., Ezaki, H., Morishita, K., & Miyake, T. (2013) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/18715222113139990008 · Cited by 49
Self-citationUsing microparticle labeling and counting for attomole-level detection in heterogeneous immunoassay
Okano, K., Takahashi, S., Yasuda, K., Tokinaga, D., Imai, K., & Koga, M. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90217-u · Cited by 30
The Effect of L-citrulline Ingestion on ECG QT Interval and Autonomic Nervous System Activity
Kameda, N., Okigawa, T., Kimura, T., Fujibayashi, M., Asada, T., Kinoshita, R., Baba, S., Morita, M., Morishita, K., & Moritani, T. (2011) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.2114/jpa2.30.41 · Cited by 14
Self-citation
Cited by
Sorted by citations
Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products
Wang, D., Yang, Y., Lei, Y., Tzvetkov, N. T., Liu, X., Yeung, A. W. K., Xu, S., & Atanasov, A. G. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017178 · Cited by 223
Hydrophobic deep eutectic solvents: Current progress and future directions
Zainal-Abidin, M. H., Hayyan, M., & Wong, W. F. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.03.011 · Cited by 181
Kurilshikov, A., van den Munckhof, I. C. L., Chen, L., Bonder, M. J., Schraa, K., Rutten, J. H. W., Riksen, N. P., de Graaf, J., Oosting, M., Sanna, S., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314642 · Cited by 178
Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine
Morris, C. R., Hamilton‐Reeves, J. M., Martindale, R. G., Sarav, M., & Ochoa, J. B. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617691250 · Cited by 162
The Effects of Oral l-Arginine and l-Citrulline Supplementation on Blood Pressure
Khalaf, D., Krüger, M., Wehland, M., Infanger, M., & Grimm, D. G. (2019) · Nutrients · doi:10.3390/nu11071679 · Cited by 145
Metadata
- Authors
- Morita, M., Hayashi, T., Ochiai, M., Maeda, M., Yamaguchi, T., Ina, K., & Kuzuya, M.
- Affiliations
- Nagoya University (JP)
- Corresponding author
- Hayashi, Toshio
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 454
- Issue
- 1
- Pages
- 53-57
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2058486417
- Cited by
- 140
- References
- 36
- Citations by year
- 2026: 14 · 2025: 8 · 2024: 14 · 2023: 13 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 17 · 2018: 10 · 2017: 7 · 2016: 6 · 2015: 2
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- KYOWA HAKKO BIO CO., LTD
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- citrulline, L-arginine, amino acid supplementation, nitric oxide bioavailability, nitric oxide-cGMP pathway, cyclic GMP, blood flow, ear artery, cardiovascular function, atherosclerosis
- MeSH terms
- Administration, Oral, Animals, Arginine, Biological Availability, Citrulline, Drug Synergism, Cyclic GMP, Humans, Male, Nitric Oxide, Rabbits, Signal Transduction, Rats, Sprague-Dawley, Dietary Supplements, Atherosclerosis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review